ARID1A and Helicobacter pylori infectious disease: As shown in Table 1, patients with EMAST+ tumors had fewer Borrmann type 3 and 4 tumors, fewer Helicobacter pylori (HP) infections, earlier pathological T categories, and more genetic mutations in the PI3K/AKT pathway and in ARID1A than those with EMAST− tumors.